Analyst Ratings for Frequency Therapeutics (FREQ)
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
N/A
Rating Score: 1.4 / 10
Percentile Rank: 10%
Rating Score: 1.4 / 10
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/26/2023 | Baird | Jack Allen | Downgrade | Neutral (Outperform) |
0.50 (4.00) |
0.38 (0.30) |
-21.05% | Details |
| 2/15/2023 | Chardan | David Gataulin | Downgrade | Neutral (Buy) |
N/A (N/A) |
0.75 (0.30) |
-60% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


